AFC
DYN icon

Ares Financial Consulting’s Dyne Therapeutics DYN Stock Holding History

Ares Financial Consulting’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87K Buy
+84
New +$1.56K ﹤0.01% 901

Other funds holding DYN

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Ares Financial Consulting's DYN Position: Q2 2026 in Review

Ares Financial Consulting opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 84 shares worth $1.87K. The stake represents ﹤0.01% of the portfolio and ranks #901 among its holdings.

12 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Ares Financial Consulting held 84 shares of Dyne Therapeutics worth $1.87K as of Q2 2026.
  • Dyne Therapeutics was a new Ares Financial Consulting position in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #901 holding.
  • 12 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.